The Medical Device Business Journal — Medical Device News & Articles | MassDevice
San Jose, Calif.-based C8 MediSensors received European CE Mark approval to launch its optical glucose monitoring system for diabetic patients.
The new non-invasive continuous glucose monitor features light spectroscopy that measures blood glucose levels without the need for frequent finger pricks.
Abbott (NYSE:ABT) said it won approval from the Japanese Ministry of Health, Labor and Welfare for its next-generation Xience Prime coronary stent
The nod means the cobalt-chromium stent is "available in all of the major markets worldwide," according to a press releaase, including the U.S., Europe, China and India.
General Electric’s (NYSE:GE) GE Capital dropped a $10 million senior secured multi-draw term loan on InfraReDx for its intravascular ultrasound technology.
The Burlington, Mass.-based company plans to use the cash to commercialization its TVC imaging system, which combines IVUS and near-infrared spectroscopy to provide images of the interior of blood vessels. It’s the only FDA-device cleared for lipid core plaque detection.
